143 related articles for article (PubMed ID: 14698147)
1. Synthesis of potent and selective 2-azepanone inhibitors of human tryptase.
Zhao G; Bolton SA; Kwon C; Hartl KS; Seiler SM; Slusarchyk WA; Sutton JC; Bisacchi GS
Bioorg Med Chem Lett; 2004 Jan; 14(2):309-12. PubMed ID: 14698147
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of potent and highly selective inhibitors of human tryptase.
Slusarchyk WA; Bolton SA; Hartl KS; Huang MH; Jacobs G; Meng W; Ogletree ML; Pi Z; Schumacher WA; Seiler SM; Sutton JC; Treuner U; Zahler R; Zhao G; Bisacchi GS
Bioorg Med Chem Lett; 2002 Nov; 12(21):3235-8. PubMed ID: 12372541
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of potent and highly selective nonguanidine azetidinone inhibitors of human tryptase.
Bisacchi GS; Slusarchyk WA; Bolton SA; Hartl KS; Jacobs G; Mathur A; Meng W; Ogletree ML; Pi Z; Sutton JC; Treuner U; Zahler R; Zhao G; Seiler SM
Bioorg Med Chem Lett; 2004 May; 14(9):2227-31. PubMed ID: 15081014
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of 4-substituted benzylamine derivatives as beta-tryptase inhibitors.
Miyazaki Y; Kato Y; Manabe T; Shimada H; Mizuno M; Egusa T; Ohkouchi M; Shiromizu I; Matsusue T; Yamamoto I
Bioorg Med Chem Lett; 2006 Jun; 16(11):2986-90. PubMed ID: 16540315
[TBL] [Abstract][Full Text] [Related]
5. Dibasic inhibitors of human mast cell tryptase. Part 2: structure-activity relationships and requirements for potent activity.
Rice KD; Wang VR; Gangloff AR; Kuo EY; Dener JM; Newcomb WS; Young WB; Putnam D; Cregar L; Wong M; Simpson PJ
Bioorg Med Chem Lett; 2000 Oct; 10(20):2361-6. PubMed ID: 11055356
[TBL] [Abstract][Full Text] [Related]
6. Potent, small-molecule inhibitors of human mast cell tryptase. Antiasthmatic action of a dipeptide-based transition-state analogue containing a benzothiazole ketone.
Costanzo MJ; Yabut SC; Almond HR; Andrade-Gordon P; Corcoran TW; De Garavilla L; Kauffman JA; Abraham WM; Recacha R; Chattopadhyay D; Maryanoff BE
J Med Chem; 2003 Aug; 46(18):3865-76. PubMed ID: 12930148
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and SAR of 4-carboxy-2-azetidinone mechanism-based tryptase inhibitors.
Sutton JC; Bolton SA; Hartl KS; Huang MH; Jacobs G; Meng W; Ogletree ML; Pi Z; Schumacher WA; Seiler SM; Slusarchyk WA; Treuner U; Zahler R; Zhao G; Bisacchi GS
Bioorg Med Chem Lett; 2002 Nov; 12(21):3229-33. PubMed ID: 12372540
[TBL] [Abstract][Full Text] [Related]
8. Bis(5-amidino-2-benzimidazolyl)methane and related amidines are potent, reversible inhibitors of mast cell tryptases.
Caughey GH; Raymond WW; Bacci E; Lombardy RJ; Tidwell RR
J Pharmacol Exp Ther; 1993 Feb; 264(2):676-82. PubMed ID: 8437115
[TBL] [Abstract][Full Text] [Related]
9. Inhibitors of tryptase for the treatment of mast cell-mediated diseases.
Rice KD; Tanaka RD; Katz BA; Numerof RP; Moore WR
Curr Pharm Des; 1998 Oct; 4(5):381-96. PubMed ID: 10197050
[TBL] [Abstract][Full Text] [Related]
10. 1,2-Benzisothiazol-3-one 1,1-dioxide inhibitors of human mast cell tryptase.
Combrink KD; Gülgeze HB; Meanwell NA; Pearce BC; Zulan P; Bisacchi GS; Roberts DG; Stanley P; Seiler SM
J Med Chem; 1998 Nov; 41(24):4854-60. PubMed ID: 9822554
[TBL] [Abstract][Full Text] [Related]
11. Novel pyrazinone inhibitors of mast cell tryptase: synthesis and SAR evaluation.
Hopkins C; Neuenschwander K; Scotese A; Jackson S; Nieduzak T; Pauls H; Liang G; Sides K; Cramer D; Cairns J; Maignan S; Mathieu M
Bioorg Med Chem Lett; 2004 Oct; 14(19):4819-23. PubMed ID: 15341931
[TBL] [Abstract][Full Text] [Related]
12. Dibasic inhibitors of human mast cell tryptase. Part 1: synthesis and optimization of a novel class of inhibitors.
Rice KD; Gangloff AR; Kuo EY; Dener JM; Wang VR; Lum R; Newcomb WS; Havel C; Putnam D; Cregar L; Wong M; Warne RL
Bioorg Med Chem Lett; 2000 Oct; 10(20):2357-60. PubMed ID: 11055355
[TBL] [Abstract][Full Text] [Related]
13. Polycationic peptides as inhibitors of mast cell serine proteases.
Lundequist A; Juliano MA; Juliano L; Pejler G
Biochem Pharmacol; 2003 Apr; 65(7):1171-80. PubMed ID: 12663052
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of diphenyl phosphonate esters as inhibitors of the trypsin-like granzymes A and K and mast cell tryptase.
Jackson DS; Fraser SA; Ni LM; Kam CM; Winkler U; Johnson DA; Froelich CJ; Hudig D; Powers JC
J Med Chem; 1998 Jun; 41(13):2289-301. PubMed ID: 9632362
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of human beta-tryptase by Bowman-Birk inhibitor derived peptides.
Scarpi D; McBride JD; Leatherbarrow RJ
J Pept Res; 2002 Feb; 59(2):90-3. PubMed ID: 11906611
[TBL] [Abstract][Full Text] [Related]
16. Tryptase inhibition blocks airway inflammation in a mouse asthma model.
Oh SW; Pae CI; Lee DK; Jones F; Chiang GK; Kim HO; Moon SH; Cao B; Ogbu C; Jeong KW; Kozu G; Nakanishi H; Kahn M; Chi EY; Henderson WR
J Immunol; 2002 Feb; 168(4):1992-2000. PubMed ID: 11823536
[TBL] [Abstract][Full Text] [Related]
17. 1,2,5-Thiadiazolidin-3-one 1,1-dioxide-based heterocyclic sulfides are potent inhibitors of human tryptase.
Wong T; Groutas CS; Mohan S; Lai Z; Alliston KR; Vu N; Schechter NM; Groutas WC
Arch Biochem Biophys; 2005 Apr; 436(1):1-7. PubMed ID: 15752703
[TBL] [Abstract][Full Text] [Related]
18. Solid-phase synthesis and SAR of 4-carboxy-2-azetidinone mechanism-based tryptase inhibitors.
Sutton JC; Bolton SA; Davis ME; Hartl KS; Jacobson B; Mathur A; Ogletree ML; Slusarchyk WA; Zahler R; Seiler SM; Bisacchi GS
Bioorg Med Chem Lett; 2004 May; 14(9):2233-9. PubMed ID: 15081015
[TBL] [Abstract][Full Text] [Related]
19. Heparin antagonists are potent inhibitors of mast cell tryptase.
Hallgren J; Estrada S; Karlson U; Alving K; Pejler G
Biochemistry; 2001 Jun; 40(24):7342-9. PubMed ID: 11401583
[TBL] [Abstract][Full Text] [Related]
20. Solid-phase synthesis of benzisothiazolones as serine protease inhibitors.
Yu KL; Civiello R; Roberts DG; Seiler SM; Meanwell NA
Bioorg Med Chem Lett; 1999 Mar; 9(5):663-6. PubMed ID: 10201825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
